<DOC>
	<DOCNO>NCT00247936</DOCNO>
	<brief_summary>Esophagectomy benign malignant disease esophagus perform use transhiatal technique Ivor Lewis technique ( combined laparotomy thoracotomy ) . These procedure associate significant morbidity mortality [ 1 ] . Advances minimally invasive technology surgical technique allow u explore possibility perform esophagectomy use minimally invasive surgical technique . Minimally invasive esophagectomy represent new alternative conventional open esophagectomy . It technically demand operation require advanced laparoscopic surgical skill , appropriate instrumentation , thorough knowledge open esophagectomy . Multiple author report use video-assisted thoracoscopy laparoscopy facilitate esophagectomy [ 2-6 ] . Most report utilized standard laparotomy combination thoracoscopy perform esophageal mobilization laparoscopy mini-laparotomy perform esophagectomy . DePaula first report large series 48 patient undergoing laparoscopic transhiatal esophagectomy benign ( n=24 ) malignant disease ( n=24 ) [ 7 ] . In 2 patient , conversion open surgery require 2 others require thoracoscopic assistance . Postoperative complication low benign group high carcinoma group . The 30-day mortality rate 16 % patient carcinoma undergoing laparoscopic transhiatal esophagectomy . DePaula conclude patient benefit procedure benign disease . Swanstrom recently report nine case laparoscopic total esophagectomy [ 8 ] . There conversion laparotomy . One patient require right thoracoscopy intrathoracic anastomosis due poor viability gastric tube . The mean operative time 6.5 hour mean hospital stay 6.4 day . However , advantage minimally invasive esophagectomy observe . The aim prospective trial evaluate physiologic outcome , clinical outcome , quality life combine thoracoscopic laparoscopic esophagectomy vs. transhiatal esophagectomy .</brief_summary>
	<brief_title>Combined Thoracoscopic Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy : A Prospective Trial .</brief_title>
	<detailed_description>RATIONALE : Open esophagectomy associate significant morbidity . We hypothesize laparoscopic esophagectomy associate reduced morbidity faster recovery . HYPOTHESES : 1 . Combined thoracoscopic laparoscopic esophagectomy perform safely . 2 . Combined thoracoscopic laparoscopic esophagectomy associate reduce postoperative pain , decrease ICU hospital stay , reduce postoperative wound morbidity . 3 . Combined thoracoscopic laparoscopic esophagectomy associate similar long term survival open approach patient esophageal malignancy . OBJECTIVES AND SPECIFIC AIMS : 1 . To compare short-term outcome operative time , operative in-patient cost , operative complication , length hospital stay , postoperative complication combine thoracoscopic/ laparoscopic esophagectomy transhiatal esophagectomy . 2 . To evaluate physiologic outcome minimally invasive esophagectomy vs. transhiatal esophagectomy . 3 . To determine long-term outcome , disease-free survival , survival quality life minimally invasive esophagectomy compare transhiatal esophagectomy</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>1 . Patients biopsy proven esophageal malignancy 2 . Patients recalcitrant severe esophageal stricture 3 . Karnofsky score &gt; 60 4 . No previous treatment cancer past 2 year ( except skin cancer ) 1 . Malignant tracheoesophageal fistula presence tracheal involvement 2 . Unacceptable operative risk 3 . Tumor size great 12 centimeter . 4 . Tumor involvement aorta trachea . 5 . Renal liver insufficiency ( Creatinine &gt; 2.0 , transaminase &gt; fourfold ) 6 . WBCs &lt; 2,000 , platelet &lt; 80,000 7 . Presence metastatic disease 8 . Patients previous esophageal resection 9 . Minors pregnant woman exclude . The chance esophageal cancer present anyone 18 year age essentially null . Pregnant woman exclude safety fetus . All physician , hospital , surgery , laboratory cost bill subject and/or insurance carrier customary consider standard care procedure . All researchrelated procedure pulmonary function test study questionnaire conduct study pay primary investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Adenocarcinoma , Esophagectomy</keyword>
</DOC>